IGFBP7 and acute kidney injury: In summary, in a population with low incidence of stage 2–3 CS-AKI, there was no evident added value of TIMP2 IGFBP7 at H6 over ∆pCrpostCPB-H6 for the early recognition of mild (stage 1) CS-AKI and of it persistent nature.